Determining accurate concentrations of drugs, toxicological substances, metabolites, trace elements and any micro- or macromolecular compound with pharmacological and therapeutic implications in humans (inpatients, outpatients, healthy individuals)

Preventive biochemical screening of newborns for over 29 disorders, including metabolic diseases (amino acid disorders, organic acidurias, fatty acid oxidation disorders, biotinidase deficiency, etc.), hormone synthesis disorders, and other conditions such as cystic fibrosis

Control of hormonal disorders in children, adolescents and adults

Characterization and quantification of cells with application in Hematology (patients with leukemias, lymphomas or immunodeficiencies), Transplantation (compatibility check), Autoimmune Diseases (detection and quantification of pathological autoantibodies), Infectiology (detection and quantification of viral load)

Targeted identification of bacterial strains for the correct administration of drugs (e.g. antibiotics) and microbiota studies

Supporting research protocols dealing with the analysis of the metabolic identity of the microbiome of various tissue types

Support of research protocols with proteomic and metabolomic analyses for the identification of new biomarkers, pharmacological targets and study of the pathogenesis of various diseases

Support of Research Programs. Technological support in research projects and subcontracting of research protocols

In vitro studies of pathogenic mechanisms and drug action

Anti-doping control

Support of Biobanks and mainly, the hub of the European network of biobanks BBMRI-ERIC (Biobanking and Biomolecular resources Research Infrastructure - European Research Infrastructure Consortium) based in the Department of Medicine, DUTH

Detection of (phyto)medicines and other substances in food (eg additives) and agricultural products for control units, agricultural cooperatives and other companies of agricultural interest and research purposes